Stock ALLO ALLOGENE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Allogene Therapeutics, Inc.

Equities

ALLO

US0197701065

Delayed Nasdaq
Other stock markets
 03:46:01 2024-05-23 pm EDT 		5-day change 1st Jan Change
2.545 USD -4.32% Intraday chart for Allogene Therapeutics, Inc. -15.45% -20.72%
May. 21 Oppenheimer Trims Allogene Therapeutics Price Target to $13 From $14, Maintains Outperform Rating MT
May. 16 HC Wainwright Adjusts Price Target on Allogene Therapeutics to $9 From $10, Keeps Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ALLO Stock
  4. Revisions Allogene Therapeutics, Inc.